CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CVTX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2009/04/18	06 : 01	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/18	05 : 32	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/18	05 : 15	Business Wire	Gilead Sciences Completes Acquisition of CV Therapeutics	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/18	02 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/18	02 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/18	02 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/18	02 : 25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/17	06 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/17	06 : 00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/17	05 : 59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/17	05 : 57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/17	05 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/17	05 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/16	04 : 54	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/14	19 : 09	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/14	19 : 06	Edgar (US Regulatory)	Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/14	06 : 23	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/14	06 : 09	Edgar (US Regulatory)	Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/10	05 : 53	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/10	05 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/10	05 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/10	05 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/10	05 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/10	05 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/10	04 : 11	Edgar (US Regulatory)	Schedule 13G	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/09	04 : 27	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/08	23 : 49	Marketwired	AnalystChoice.com Free Investment Opinion on PPDI, MEDX, CVTX and OSIP	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/07	08 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/07	05 : 12	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:CVTX	CV Therapeutics (MM)
2009/04/07	03 : 02	Edgar (US Regulatory)	Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:CVTX	CV Therapeutics (MM)